Psychemedics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Psychemedics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Psychemedics Today - Breaking & Trending Today
Psychemedics Co. (NASDAQ:PMD – Get Free Report) was the target of a large decline in short interest in October. As of October 31st, there was short interest totalling 17,800 shares, a decline of 25.8% from the October 15th total of 24,000 shares. Based on an average daily volume of 17,200 shares, the short-interest ratio is […] ....
Psychemedics (NASDAQ:PMD – Get Free Report) and HH&L Acquisition (NYSE:HHLA – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation and analyst recommendations. Institutional & Insider Ownership 24.4% of Psychemedics shares […] ....
Psychemedics (NASDAQ:PMD – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Institutional and Insider Ownership 24.4% of Psychemedics shares […] ....
Psychemedics Co. (NASDAQ:PMD – Get Rating) declared a quarterly dividend on Tuesday, May 9th, Zacks reports. Stockholders of record on Thursday, May 25th will be given a dividend of 0.07 per share on Thursday, June 8th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 5.21%. The ex-dividend date of […] ....
09.05.2023 - ACTON, Mass., May 09, 2023 (GLOBE NEWSWIRE) - Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2023, and the . ....